Assessment of cardiovascular disease in immune thrombotic thrombocytopenic purpura. [PDF]
Evangelidis P +3 more
europepmc +1 more source
Vaccine-induced thrombotic thrombocytopenic purpura
Sudha Vidyasagar
doaj +1 more source
In reply: epidemiology of immune-mediated thrombotic thrombocytopenic purpura in Germany. [PDF]
Scharenberg AY +9 more
europepmc +1 more source
Precision medicine in thrombotic thrombocytopenic purpura: a narrative review. [PDF]
Al-Shibly R +5 more
europepmc +1 more source
NETs contribute to acute episodes but not ADAMTS13 relapses in immune-mediated thrombotic thrombocytopenic purpura. [PDF]
Buonomo SM +4 more
europepmc +1 more source
The landscape of ADAMTS13-related tests in thrombotic thrombocytopenic purpura: a review. [PDF]
Meng C, Halkidis K.
europepmc +1 more source
Unmet health care needs in immune thrombotic thrombocytopenic purpura survivors. [PDF]
Story CM +3 more
europepmc +1 more source
The impact of caplacizumab in the treatment of immune thrombotic thrombocytopenic purpura. A retrospective monocentric cohort study. [PDF]
Markovic U +16 more
europepmc +1 more source
Regarding "Challenges in diagnosing thrombotic thrombocytopenic purpura". [PDF]
Martins de Oliveira Filho C, Carney BJ.
europepmc +1 more source
Rat models of thrombotic thrombocytopenic purpura reveal crucial role of placental ADAMTS13 in perinatal survival. [PDF]
Zhang Q +6 more
europepmc +1 more source

